Classification and evolution of type II CRISPR-Cas systems
Open accessAbstract
The CRISPR-Cas systems of archaeal and bacterial adaptive immunity are classified into three types that differ by the repertoires of CRISPR-associated (cas) genes, the organization of cas operons and the structure of repeats in the CRISPR arrays. The simplest among the CRISPR-Cas systems is type II in which the endonuclease activities required for the interference with foreign deoxyribonucleic acid (DNA) are concentrated in a single multidomain protein, Cas9, and are guided by a co-processed dual-tracrRNA:crRNA molecule. This compact enzymatic machinery and readily programmable site-specific DNA targeting make type II systems top candidates for a new generation of powerful tools for genomic engineering. Here we report an updated census of CRISPR-Cas systems in bacterial and archaeal genomes. Type II systems are the rarest, missing in archaea, and represented in ∼ 5% of bacterial genomes, with an over-representation among pathogens and commensals. Phylogenomic analysis suggests that at least three cas genes, cas1, cas2 and cas4, and the CRISPR repeats of the type II-B system were acquired via recombination with a type I CRISPR-Cas locus. Distant homologs of Cas9 were identified among proteins encoded by diverse transposons, suggesting that type II CRISPR-Cas evolved via recombination of mobile nuclease genes with type I loci.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Due to recognition preference of some specific bases of CRISPR/Cas9 system and diverse epigenetic landscape, different targeted gene loci may exhibit distinctive different gene editing efficiencies.
“Besides, due to the recognition preference of some specific bases of CRISPR/Cas9 system and the diverse epigenetic landscape, different targeted gene loci may exhibit distinctive different gene editing efficiencies [140, 201–203].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [202]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 84 · Cited by 498
- Authors
- Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V.
- Affiliations
- University of Vienna (AT)
- National Institutes of Health (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Koonin, Eugene V.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-11
- Volume
- 42
- Issue
- 10
- Pages
- 6091-6105
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4041416
- OpenAlex
- W2133908827
- Cited by
- 498
- References
- 84
- Citations by year
- 2026: 18 · 2025: 40 · 2024: 49 · 2023: 45 · 2022: 45 · 2021: 45 · 2020: 35 · 2019: 41 · 2018: 36 · 2017: 48 · 2016: 37 · 2015: 43 · 2014: 14 · 2013: 1
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- Nucleic Acids Research (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- Alexander von Humboldt-Stiftung
- Kempe Foundation
- Bundesministerium für Bildung und Forschung
- Vetenskapsrådet (K2013-57X-21436-04-3)
- Umeå Universitet
- Umeå Centre for Microbial Research
- U.S. National Library of Medicine
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Keywords
- Cas9, type I CRISPR-Cas, Cas1, Cas2, adaptive immunity, archaea, bacteria, phylogenomics, horizontal gene transfer, genomic engineering
- MeSH terms
- Endonucleases, Phylogeny, Genome, Bacterial, Evolution, Molecular, Genome, Archaeal, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review